Establishing safety and regulatory requirements for compounded medications.
Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
Email me when HB 2613 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 2613. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill makes it illegal to sell or distribute compounded medications unless the active ingredients meet specific FDA‑recognized standards, are pharmaceutical‑grade, and are accompanied by detailed testing and certification. It applies to pharmacies, compounding facilities, and any suppliers of bulk drug substances, and it authorizes inspections and steep fines plus license revocation for non‑compliance. The measure was introduced to protect Washington patients from unsafe or counterfeit ingredients and failed to pass.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 2613
3 free questions a day, no accountHistory
- Public hearing in the House Committee on Health Care & Wellness at 8:00 AM.
- First reading, referred to Health Care & Wellness.
Sponsors
- Thai · sponsor
- Duerr
- Hill
- Ormsby
- Parshley
- Santos
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 2613 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 2613 freeOr ask your AI assistant about HB 2613 directly:
Add to Claude, ChatGPT or Cursor